ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Investor Access Event in South Africa from January 14-16, 2025.
All investors are invited to request a registration to attend the Investor Access Event.
ASP Isotopes values transparency and open communication with all stakeholders and counterparties. During 2024, the Company welcomed over 60 investors and corporate clients to its facilities in South Africa.
The timing of the event for investors departing from the USA allows for the following schedule:
Sun, Jan 12 (evening)
Mon, Jan 13 (evening)
Tue, Jan 14 (all day)
Wed, Jan 15 (all day)
Thu, Jan 16
Fri, Jan 17 (morning) Depart USA
Arrive in South Africa
Scientific Sessions and Plant Tours
Scientific Sessions and Plant Tours
Depart South Africa
Arrive in USA
Stakeholders wishing to attend should email Viktor Petkov at vpetkov@aspisotopes.com as soon as possible to complete the registration process and receive confirmation of your place. Attendees will be required to submit a copy of their passport by December 31, 2024 in order to obtain the required security clearances to visit the Company’s secure facilities. For citizens of the USA, UK and Europe, security clearance is typically an expedient process. For other nationalities (including dual nationalities), a longer period of time may be required. Registrations for the event are subject to availability and to acceptance by the Company at its absolute discretion.
ASP Isotopes is in the process of commissioning three isotope enrichment facilities in South Africa. The first facility is scheduled to enrich Carbon-14 for use in healthcare and agrochemicals. The second facility is scheduled to enrich Silicon-28, which the Company believes will enable faster, more efficient semiconductors for use in artificial intelligence and quantum computing. The third facility is scheduled to enrich Ytterbium-176, a critically important raw material used in the production of radio-oncology therapies.
Participants of the Investor Access Event will be able to visit all three facilities as well as PET Labs, the Company’s radioisotope production center and Pelindaba, the center for South Africa Nuclear Energy Corporation (Necsa).
ASP Isotopes looks forward to welcoming as many stakeholders as possible for them to see firsthand all our facilities and hear directly from the Scientific and Engineering Teams.
